MX2023006261A - Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar la duracion del sue?o nocturno. - Google Patents
Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar la duracion del sue?o nocturno.Info
- Publication number
- MX2023006261A MX2023006261A MX2023006261A MX2023006261A MX2023006261A MX 2023006261 A MX2023006261 A MX 2023006261A MX 2023006261 A MX2023006261 A MX 2023006261A MX 2023006261 A MX2023006261 A MX 2023006261A MX 2023006261 A MX2023006261 A MX 2023006261A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- human milk
- compositions
- sleep duration
- night sleep
- Prior art date
Links
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 230000004617 sleep duration Effects 0.000 title abstract 2
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 2
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 2
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 2
- CILYIEBUXJIHCO-UHFFFAOYSA-N 102778-91-6 Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC2C(C(O)C(O)OC2CO)O)OC(CO)C1O CILYIEBUXJIHCO-UHFFFAOYSA-N 0.000 abstract 1
- DVGKRPYUFRZAQW-UHFFFAOYSA-N 3 prime Natural products CC(=O)NC1OC(CC(O)C1C(O)C(O)CO)(OC2C(O)C(CO)OC(OC3C(O)C(O)C(O)OC3CO)C2O)C(=O)O DVGKRPYUFRZAQW-UHFFFAOYSA-N 0.000 abstract 1
- OIZGSVFYNBZVIK-FHHHURIISA-N 3'-sialyllactose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O OIZGSVFYNBZVIK-FHHHURIISA-N 0.000 abstract 1
- 238000004977 Hueckel calculation Methods 0.000 abstract 1
- CILYIEBUXJIHCO-UITFWXMXSA-N N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)O[C@@H]2CO)O)O[C@H](CO)[C@@H]1O CILYIEBUXJIHCO-UITFWXMXSA-N 0.000 abstract 1
- OIZGSVFYNBZVIK-UHFFFAOYSA-N N-acetylneuraminosyl-D-lactose Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1O OIZGSVFYNBZVIK-UHFFFAOYSA-N 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pediatric Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Anesthesiology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se relaciona con una composición nutricional que comprende al menos un oligosacárido de la leche humana que comprende 3' sialillactosa (3-SL), lacto-N-tetraosa (LNT), HMO básicos y cualquier combinación de estos para mejorar la duración total del sueño nocturno en un sujeto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121584P | 2020-12-04 | 2020-12-04 | |
| PCT/EP2021/084197 WO2022117829A1 (en) | 2020-12-04 | 2021-12-03 | Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006261A true MX2023006261A (es) | 2023-06-12 |
Family
ID=78844601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006261A MX2023006261A (es) | 2020-12-04 | 2021-12-03 | Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar la duracion del sue?o nocturno. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240000122A1 (es) |
| EP (1) | EP4255222A1 (es) |
| CN (1) | CN116490079A (es) |
| MX (1) | MX2023006261A (es) |
| WO (1) | WO2022117829A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11849747B1 (en) | 2019-06-24 | 2023-12-26 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
| US12005083B1 (en) | 2019-06-24 | 2024-06-11 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11957148B2 (en) * | 2015-12-15 | 2024-04-16 | Societe Des Produits Nestle S.A. | Mixture of human milk oligosaccharides(HMOs) |
| WO2019121929A1 (en) * | 2017-12-22 | 2019-06-27 | Societe Des Produits Nestle S.A. | Compositions for use in the reduction of nociception in infants and young children |
-
2021
- 2021-12-03 US US18/255,768 patent/US20240000122A1/en active Pending
- 2021-12-03 WO PCT/EP2021/084197 patent/WO2022117829A1/en active Application Filing
- 2021-12-03 EP EP21823883.0A patent/EP4255222A1/en active Pending
- 2021-12-03 CN CN202180080349.9A patent/CN116490079A/zh active Pending
- 2021-12-03 MX MX2023006261A patent/MX2023006261A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022117829A1 (en) | 2022-06-09 |
| CN116490079A (zh) | 2023-07-25 |
| EP4255222A1 (en) | 2023-10-11 |
| US20240000122A1 (en) | 2024-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023006261A (es) | Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar la duracion del sue?o nocturno. | |
| EP2123282A3 (en) | Immunemodulating oligosaccharides | |
| EP2374362A3 (en) | Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants | |
| NZ599302A (en) | Preventing diseases in infants delivered via caesarean section | |
| WO2010056730A3 (en) | Dental implant | |
| UA89791C2 (ru) | Пищевая композиция, которая содержит неусваиваемые олигосахариды, для лечения или профилактики инфекций респираторного тракта | |
| HK1066174A1 (en) | Lactic acid bacteria and/or bifidobacteria, a composition containing the same and the use thereof | |
| MXPA01013239A (es) | Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias. | |
| NZ612504A (en) | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents | |
| EP2671584A3 (en) | Compositions and methods for treating disorders associated with salt or fluid retention | |
| EP2204176A3 (en) | Nutritional Composition | |
| PH12018501297A1 (en) | Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders | |
| WO2012087742A3 (en) | Methods and compositions suitable for managing blood glucose in animals | |
| ZA200206696B (en) | Viscoelastics for use in middle ear surgery. | |
| Nassani et al. | Reappraisal of the removable partial denture as a treatment option for the shortened dental arch | |
| SG171625A1 (en) | Antiseptic-containing silicone elastomers | |
| WO2008129180A3 (fr) | Nouveaux facteurs viii pour le traitement des hemophiles de type a | |
| MX2023012062A (es) | Composiciones para el cuidado bucal que comprenden copolimero de bloque. | |
| EP4327815A3 (en) | Probiotics for regulating blood glucose | |
| MX2009011214A (es) | Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. | |
| 小野大輔 | Lateral bone augmentation with newly developed β-tricalcium phosphate block: an experimental study in the rabbit mandible | |
| UA32262A (uk) | Зубна паста |